Doubling Tamiflu Dose No Better for Severe Flu: Study

Friday, 31 May 2013 08:15 AM

 

Share:
  Comment  |
   Contact Us  |
  Print  
|  A   A  
  Copy Shortlink
People with a severe case of the flu don't benefit from taking double doses of the antiviral drug Tamiflu, according to a new study conducted in Southeast Asia.
 
Tamiflu (oseltamivir) stocks could be conserved during pandemics if doctors prescribe only standard doses of this medication, World Health Organization experts suggested.
 
The study involved 326 patients diagnosed with severe flu at 13 hospitals in Indonesia, Singapore, Thailand and Vietnam between April 2007 and February 2010. Most of the patients were children younger than 15, but some adults also were included.
 
Health-care workers treated the patients with either a standard dose of Tamiflu (75 milligrams twice daily or the children's equivalent), or a double dose of the medication (150 milligrams twice daily or children's equivalent) over the course of five days.
 
Patients' virus levels were measured through nose and throat swabs. Researchers then tracked how many patients died, were admitted to the intensive care unit or required the help of a ventilator to breathe.
 
After five days of treatment, there were no differences between the patients on a standard dose of Tamiflu and those given the double dose. Moreover, no differences were seen in death rates or other adverse events, the study found.
 
The findings were published online May 30 in the journal BMJ.
 
The study authors concluded that there's no added benefit from a higher dose of Tamiflu to treat severe flu, according to a journal news release.
 
In an accompanying editorial, Ian Barr and Aeron Hurt from the WHO Collaborating Centre for Reference and Research on Influenza, wrote that a double dose of Tamiflu "is unlikely to significantly improve the clinical outcomes of severe cases of seasonal influenza."
 
They added that the study's findings "could help to preserve oseltamivir (Tamiflu) stocks during a future pandemic if clinicians were to prescribe only regular rather than double doses."

They noted, however, that flu treatment options must be expanded and further research is needed on more effective combinations of drugs.

© HealthDay

Share:
  Comment  |
   Contact Us  |
  Print  
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Country
Zip Code:
Privacy: We never share your email.
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

Kids' Get Antibiotics Twice as Often as Needed: Study

Monday, 15 Sep 2014 17:09 PM

Pediatricians prescribe antibiotics about twice as often as they're actually needed for children with ear and throat inf . . .

Bald Men Have Higher Prostate Cancer Risk: Study

Monday, 15 Sep 2014 17:01 PM

Men with male pattern baldness may face a higher risk of developing an aggressive type of prostate cancer than men with  . . .

Drugmaker Agrees to Cheaper Versions of $1,000-a-Pill Hepatitis Med

Monday, 15 Sep 2014 16:51 PM

U.S. drugmaker Gilead Sciences Inc has licensed its hepatitis C drug Sovaldi to seven India-based drugmakers that will s . . .

Most Commented

Newsmax, Moneynews, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, NewsmaxWorld, NewsmaxHealth, are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved